Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Molecular medical research points to treatment of spinal muscular atrophy

06.11.2007
SMA is the second most prevalent genetic cause of infant death in the UK, after cystic fibrosis.

Studies show that between 1:50 and 1:34 of the population are carriers of the disease, and that it affects in the region of 1:10,000 children born in the UK. In the USA, 1:40 are carriers and 1:6,000 children are affected by the disease.

SMA is a neuromuscular condition causing weakness of the muscles. The gene for SMA is passed from parents to their children, but SMA can only affect a child if both parents carry a defective gene. Genes come in pairs, one from each parent. If a person has one normal and one affected gene they do not show the symptoms of SMA but are carriers. If both genes are affected they will have SMA.

Researchers at the Peninsula Medical School in Exeter, UK, have carried out studies into one of the two survival motor neuron (SMN) genes that set suffers from SMA apart from the rest of the population. In 98% of SMA sufferers, the SMN protein is only produced from one of these genes. The resulting fall in SMN protein levels is what causes SMA to develop.

The remaining two per cent of SMA sufferers produce normal levels of SMN protein, but the protein is altered so that it is no longer capable of performing its normal functions within the body. One of the main reasons for this is that these disease-causing alterations in the SMN protein prevent it from localising to the correct places in the body¡¯s cells. By looking at why mutations occur and what they do to divert protein away from the cellular areas where it is required, the Peninsula Medical School team may be able to identify compounds that alter the protein so that it is directed correctly ¨C effectively producing a treatment for the disease.

The research could also have potential bearings on other treatments, such as gene therapy.

The paper highlighting this research is the first to be published by this particular research team, and it has made the front cover of ¡°Human Molecular Genetics¡± ¨C a remarkable achievement for a first time publication.

The research team is developing a number of other research projects in this area, as well as looking at non-invasive ways of carrying out tests in clinical trials ¨C such as identifying SMA from saliva rather than blood samples.

The team is headed up by Dr. Philip Young, researcher and lecturer in biomedical science at the Peninsula Medical School. He said: ¡°Although our results have no initial translational impact on patients, they highlight why alterations in the SMN protein could prevent it from functioning properly. This is important because if we can help the altered protein function we could potentially identify a novel therapeutic approach.¡±

Richard Green, chief executive of The Jennifer Trust for Spinal Muscular Atrophy, added: ¡°Every advance in the scientific understanding of this devastating condition brings us another step closer to an effective treatment. New discoveries lead to new hope for the many thousands of families affected by SMA. We are very pleased to hear this news.¡±

For more information about SMA research at the Peninsula Medical School, or if SMA affects you and your family and you would like to get involved, please contact Phil Young on 01392 262939 or email him at philip.young@pms.ac.uk.

Case Study

Twins Bethany and Ceri Astill, 11, from Torpoint, Plymouth, UK, were diagnosed with type 2 SMA around the time of their second birthday.

Mum Sian said: ¡°We noticed that they were slow in trying to walk, and were intent on using their own unique ways of getting around. They were given the ¡®lazy label¡¯ for a while, but a little after their first birthday our GP referred them to Derriford where they had a number of tests. A genetic blood test a few months later confirmed that they had type 2 SMA.¡±

The girls are determined to be as much the same as other youngsters of their age, and they have always attended mainstream schools with the support of one-to-one carers. They have just started at Torpoint Community College, and they have a passion for music and drama.

Said Sian: ¡°Although they have the daily struggle of getting around and doing everyday things that you or I take for granted, they are remarkably positive and outgoing ¨C so much so that we are often put in contact with families with recently diagnosed children to offer support and to explain how the condition can affect daily life.¡±

Despite both undergoing spinal surgery in late June, the girls remain upbeat and are not adverse to turning down challenges from the most well-known of challenge makers ¨C Anika Rice. Earlier this year they took part in a Challenge Anika programme that was broadcast in early June, to raise money for the children¡¯s hospice movement. The girls and Sian were flown to London on Mohammed Al-Faed¡¯s private helicopter, and even recorded a track for a charity album with Duncan James from Blue.

Said Sian: ¡°There¡¯s really no stopping them, and we are so proud of the way they go about dealing with their condition.¡±

But what does the family think about the research breakthrough discovered at the Peninsula Medical School? ¡°Even if it might not be beneficial to our girls, if it does anything to help anybody else in our situation it has to be brilliant.

Andrew Gould | EurekAlert!
Further information:
http://www.pms.ac.uk/pms/

More articles from Health and Medicine:

nachricht GLUT5 fluorescent probe fingerprints cancer cells
20.04.2018 | Michigan Technological University

nachricht Scientists re-create brain neurons to study obesity and personalize treatment
20.04.2018 | Cedars-Sinai Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Molecules Brilliantly Illuminated

Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.

Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Structured light and nanomaterials open new ways to tailor light at the nanoscale

23.04.2018 | Physics and Astronomy

On the shape of the 'petal' for the dissipation curve

23.04.2018 | Physics and Astronomy

Clean and Efficient – Fraunhofer ISE Presents Hydrogen Technologies at the HANNOVER MESSE 2018

23.04.2018 | Trade Fair News

VideoLinks
Science & Research
Overview of more VideoLinks >>>